SupplementScience
meta analysis2,569 participants

Berberine and Blood Sugar Control: 2019 Meta-Analysis

DJP
Reviewed by , MD, Board Certified Internal Medicine

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

A 2019 meta-analysis (n=2,569) found that berberine significantly reduced fasting blood glucose by 0.87 mmol/L, HbA1c by 0.72%, and improved insulin sensitivity. These effects were comparable to metformin in head-to-head trials. Berberine also provided additional lipid-lowering benefits not seen with metformin alone. Note: These findings do not justify replacing prescribed diabetes medication without medical supervision.

Key Findings

  • Berberine reduced fasting blood glucose by a weighted mean of 0.87 mmol/L (15.7 mg/dL) compared to placebo (95% CI: -1.09 to -0.65, p < 0.001)
  • HbA1c decreased by 0.72 percentage points (95% CI: -0.94 to -0.50), indicating clinically meaningful improvement in long-term glycemic control comparable to some oral diabetes medications
  • Berberine activates AMPK (AMP-activated protein kinase), the same master metabolic switch targeted by metformin, increasing glucose uptake in muscle cells and reducing hepatic glucose output
  • In the landmark Yin et al. (2008) head-to-head trial, berberine 500mg 3x/day produced comparable fasting glucose and HbA1c reductions to metformin 500mg 3x/day over 3 months in newly diagnosed type 2 diabetes patients
  • Berberine additionally reduced total cholesterol by 0.61 mmol/L, LDL by 0.65 mmol/L, and triglycerides by 0.50 mmol/L — a lipid-lowering effect not observed with metformin monotherapy

Study Details

Efficacy of berberine in patients with type 2 diabetes mellitus
Yin J, Xing H, Ye J — Metabolism (2008)
Berberine 500mg 3x/day reduced fasting blood glucose by 25.9% and HbA1c by 18.1% over 3 months, comparable to metformin in a parallel group
116 participantsHigh
Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis
Liang Y, Xu X, Yin M, Zhang Y, Huang L, Chen R, Ni J — Endocrine Journal (2019)
Meta-analysis of 28 trials confirmed berberine significantly reduces fasting glucose, HbA1c, and lipid markers in type 2 diabetes patients
2,569 participantsHigh

Practical Takeaway

Berberine at 500mg 2-3x/day with meals shows meaningful blood sugar and lipid-lowering effects and may be a reasonable supplement for prediabetes and metabolic syndrome under medical guidance. However, it should not replace prescribed metformin or other diabetes medications without physician supervision. The most common side effect is GI discomfort (diarrhea, constipation), which typically resolves within 1-2 weeks. Berberine has significant drug interactions — consult your doctor before use, especially if taking diabetes medications, statins, or blood thinners.

Summary

A systematic review and meta-analysis examining the effects of berberine supplementation on glycemic control markers — fasting blood glucose, HbA1c, and insulin resistance — across clinical trials involving 2,569 participants with type 2 diabetes or metabolic syndrome.

Related Supplements

Berberine

References

  1. (). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. DOI
  2. (). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal. DOI
  3. (). Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. DOI